Trevi Therapeutics
(NASDAQ:TRVI)
Trevi Therapeutics, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Trevi Therapeutics, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$4.11
-0.16[-3.75%]
At close: Aug 12
$3.95
-0.1600[-3.89%]
After Hours: 5:26PM EDT
Day High/Low4.08 - 4.6
52 Week High/Low0.46 - 4.68
Open / Close4.6 / 4.11
Float / Outstanding21.7M / 38.7M
Vol / Avg.188.9K / 1.4M
Mkt Cap159M
P/E-
50d Avg. Price3.11
Div / Yield-
Payout Ratio-
EPS-0.24
Total Float21.7M

Trevi Therapeutics (NASDAQ:TRVI), Quotes and News Summary

Trevi Therapeutics (NASDAQ: TRVI)

Day High/Low4.08 - 4.6
52 Week High/Low0.46 - 4.68
Open / Close4.6 / 4.11
Float / Outstanding21.7M / 38.7M
Vol / Avg.188.9K / 1.4M
Mkt Cap159M
P/E-
50d Avg. Price3.11
Div / Yield-
Payout Ratio-
EPS-0.24
Total Float21.7M
Sector: Health Care.Industry: Pharmaceuticals
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, or IPF, and levodopa-induced dyskinesia, or LID, in patients with Parkinson's disease.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Trevi Therapeutics Questions & Answers

Q
How do I buy Trevi Therapeutics (TRVI) stock?
A

You can purchase shares of Trevi Therapeutics (NASDAQ: TRVI) through any online brokerage.

View our list of the best stock brokerages.

Q
What is the target price for Trevi Therapeutics (TRVI) stock?
A

The latest price target for Trevi Therapeutics (NASDAQ: TRVI) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting TRVI to fall to within 12 months (a possible -2.68% downside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Trevi Therapeutics (TRVI)?
A

The stock price for Trevi Therapeutics (NASDAQ: TRVI) is $4.11 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Trevi Therapeutics (TRVI) pay a dividend?
A

The next Trevi Therapeutics (TRVI) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Trevi Therapeutics (NASDAQ:TRVI) reporting earnings?
A

Trevi Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Trevi Therapeutics (TRVI) going to split?
A

There is no upcoming split for Trevi Therapeutics.

Q
What sector and industry does Trevi Therapeutics (TRVI) operate in?
A

Trevi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.